Winter Peptide Protocol: Immune Defense, Sleep Optimization, and Bulk Phase GH Peptides

Winter is a season of competing demands on the body. Immune challenges peak as respiratory viruses reach maximum circulation. Reduced sunlight depresses vitamin D and serotonin. Cold itself creates physiological stress. And for many, winter is the traditional bulk phase — when dietary surplus and training for hypertrophy can be optimized with targeted peptide support.

A comprehensive winter protocol addresses all of these simultaneously: maintaining the immune defenses established in fall, leveraging the longer nights for deep sleep optimization, and using growth hormone secretagogues to maximize the anabolic return on a winter training block.

Maintaining Immune Defense Through Winter

By December, the fall immune-prep protocol (TA-1 and LL-37) will have been running for 10–12 weeks. At this point, immune education has occurred and the intensive phase can be reduced to a maintenance schedule.

Winter immune maintenance: TA-1 500 mcg–1 mg once per week as maintenance (versus 2–3x/week in fall). LL-37 100–150 mcg twice per week to maintain mucosal antimicrobial activity. Vitamin D3 continues at the same dose established in fall — many people require more in winter to maintain the same serum level due to reduced UV exposure even at lower baseline doses.

At the first sign of acute infection, consider bumping TA-1 back to 1 mg every other day for 1–2 weeks as an acute immune support course. This mirrors how TA-1 is used clinically in immunocompromised patients.

DSIP: Deep Sleep in Long Winter Nights

Delta Sleep-Inducing Peptide (DSIP) is a nonapeptide that was originally isolated from rabbit cerebral spinal fluid in 1977 and has been studied since for its role in sleep architecture, stress adaptation, and neuroendocrine regulation.

DSIP does not induce sedation in the way that pharmaceutical sleep aids do. Instead, it modulates delta wave (slow-wave) sleep — the deepest, most physically restorative phase of the sleep cycle. SWS is when growth hormone secretion peaks, muscle protein synthesis is highest, immune consolidation occurs, and memory is encoded from short-term to long-term storage.

Research has shown DSIP normalizes disrupted sleep patterns and can reduce sleep latency, extend total sleep time, and improve the ratio of restorative to light sleep. Interestingly, it also appears to blunt cortisol responses to stress — relevant in winter when seasonal affective symptoms and holiday-period psychological stress are common.

Winter protocol: 200–500 mcg DSIP subcutaneous injection 30–45 minutes before bed. This is not a nightly compound for indefinite use; cycle it as needed during periods of sleep disruption, or run structured courses of 2–3 weeks followed by breaks. Many users find it most valuable during the holiday-to-January period when schedule disruptions are most common.

CJC-1295 and Ipamorelin: The Winter Bulk Stack

The longer winter nights create a practical advantage for GH peptide protocols: more hours of darkness means more potential GH pulse windows, and the traditional dietary surplus of winter bulking provides the substrate that GH-stimulated anabolism requires.

CJC-1295 (without DAC) is a growth hormone releasing hormone (GHRH) analog that stimulates pituitary GH release. When combined with Ipamorelin (a selective GH secretagogue that acts on ghrelin receptors), the combination produces a synergistic, physiologically timed GH pulse without the cortisol and prolactin elevation seen with older peptides like GHRP-6.

Winter bulk protocol:

• Before bed: CJC-1295 (no DAC) 100 mcg + Ipamorelin 200 mcg subcutaneous injection
• Morning fasted (optional second pulse): CJC-1295 100 mcg + Ipamorelin 100–200 mcg

The bedtime injection takes advantage of natural growth hormone peaks in the first 90 minutes of sleep. The optional morning pulse provides additional lipolytic and anabolic stimulus without significantly affecting daytime insulin sensitivity when doses are kept in the range above.

Run this combination for 12–16 weeks during the bulk phase, then reassess at the end of winter before transitioning to a spring cutting protocol.

GHRP-2 for Enhanced GH Secretion

For individuals with blunted GH secretion (common in those over 35–40) or those seeking more aggressive bulk-phase support, GHRP-2 can be substituted for Ipamorelin or added at lower doses.

GHRP-2 produces stronger GH pulses than Ipamorelin but with some increases in cortisol and prolactin that make it less elegant for long-term use. In a winter bulk context, 100 mcg GHRP-2 combined with CJC-1295 before bed generates robust GH pulses that support lean tissue accretion during caloric surplus.

The trade-off: GHRP-2 increases appetite significantly (through ghrelin-related mechanisms), which can be advantageous or disadvantageous depending on your relationship with food intake during a bulk.

BPC-157 for Winter Training Volume

Increased winter training volume creates cumulative joint and tendon stress. Maintaining BPC-157 at a lower maintenance dose (250 mcg 3–4x/week) through winter training protects the connective tissue that heavy compound lifting taxes most — particularly knees, hips, shoulders, and the lower back.

This dose is sufficient for preventative effect without requiring the full 500 mcg daily dose appropriate for active injury treatment.

The Cold Exposure Synergy

Cold exposure (sauna and cold contrast, cold plunges, or regular cold showers) has documented effects on GH pulse amplitude. A study from 1994 showed that cold exposure can double peak GH levels in healthy subjects. For winter peptide users, cold exposure in the morning creates a complementary GH-amplifying stimulus to the evening secretagogue injections.

The cold-GH axis, combined with DSIP-enhanced slow-wave sleep and CJC/Ipamorelin GH pulses, creates a powerful convergence of anabolic signaling during winter months.

Winter Protocol Overview

| Time | Compound | Dose/Frequency | |------|----------|---------------| | Morning | Vitamin D3 + K2 | 4,000–6,000 IU / 200 mcg | | Morning fasted (optional) | CJC-1295 + Ipamorelin | 100 mcg / 150 mcg | | 2x/week | TA-1 maintenance | 1 mg | | 2x/week | LL-37 maintenance | 100 mcg | | 3–4x/week | BPC-157 | 250 mcg | | Before bed | CJC-1295 + Ipamorelin | 100 mcg / 200 mcg | | As needed (2–3 week courses) | DSIP | 300–500 mcg |

This protocol runs December through February, then begins winding down into the spring transition. For context on the full annual cycle, see our annual peptide cycling plan.

Read peptide evening routine for a detailed breakdown of pre-bed peptide timing and stacking, and 30-day peptide challenge if you're new to this and want a structured entry point.

Frequently Asked Questions

Q: Will GH secretagogues cause me to gain fat during winter? GH peptides like CJC-1295/Ipamorelin stimulate lipolysis as well as anabolism. During a caloric surplus, the net effect is increased lean mass accretion relative to fat gain — you're making the bulk "cleaner" rather than eliminating fat gain entirely. Keeping the dietary surplus modest (200–300 calories above maintenance) amplifies this.

Q: Is DSIP addictive or habit-forming? No. DSIP is not a GABA modulator or sedative compound. It works through natural sleep architecture modulation and does not create dependence. Anecdotally, users report that benefits persist after stopping and that it doesn't cause tolerance with cycling use.

Q: How do I know if my GH peptide injections are working? Key indicators in the first 4–8 weeks: improved sleep quality, more vivid dreams (a classic sign of increased GH during sleep), morning skin firmness, and reduced recovery time from training. By 8–12 weeks, body composition changes (increased lean mass, slight reduction in waist circumference even during a bulk) become measurable.

Q: Can I use DSIP and GH peptides on the same night? Yes. Many users stack DSIP with CJC-1295/Ipamorelin before bed. The combination provides both sleep architecture optimization and a GH pulse at sleep onset — which is when the largest natural GH pulse of the 24-hour period occurs anyway.

Q: What blood markers should I track during a winter GH peptide protocol? Baseline and 8-week follow-up: IGF-1 (reflects cumulative GH secretion), fasting glucose and HbA1c (GH can mildly affect insulin sensitivity at higher doses), and a basic metabolic panel. IGF-1 should remain in the normal range; if it climbs significantly above reference range, reduce the GH peptide dose.